INS and gestational diabetes: Variation in ADCY5 increases fasting glucose levels and type 2 diabetes risk through altered expression in beta cells and impaired glucose signalling [33] and has been found to decrease the disposition index (an indicator of insulin secretion capacity) in women with gestational diabetes after adjusting for BMI [34].